GeneNews (GEN) Stock Price Up 6.3%

Share on StockTwits

Shares of GeneNews Ltd (TSE:GEN) rose 6.3% on Friday . The company traded as high as C$0.17 and last traded at C$0.17. Approximately 414,702 shares were traded during trading, a decline of 80% from the average daily volume of 2,057,239 shares. The stock had previously closed at C$0.16.

The firm has a market capitalization of $22.97 million and a price-to-earnings ratio of -4.71.

ILLEGAL ACTIVITY NOTICE: “GeneNews (GEN) Stock Price Up 6.3%” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4244501/genenews-gen-stock-price-up-6-3.html.

About GeneNews (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Recommended Story: The mechanics of the bid-ask spread in trading

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Maxim Group Reaffirms Hold Rating for Pure Storage
Maxim Group Reaffirms Hold Rating for Pure Storage
Morgan Stanley Raises Sempra Energy  Price Target to $142.00
Morgan Stanley Raises Sempra Energy Price Target to $142.00
Target  Given a $105.00 Price Target at Bank of America
Target Given a $105.00 Price Target at Bank of America
US Well Services  versus KLX Energy Services  Head-To-Head Review
US Well Services versus KLX Energy Services Head-To-Head Review
$864.60 Million in Sales Expected for Cabot Corp  This Quarter
$864.60 Million in Sales Expected for Cabot Corp This Quarter
Telsey Advisory Group Reaffirms “Outperform” Rating for Lowe’s Companies
Telsey Advisory Group Reaffirms “Outperform” Rating for Lowe’s Companies


© 2006-2019 Ticker Report